Søgning
Søgning på udtrykket 'hepatitis b' giver 41 resultater
Dokumenter [4]
Sider [2]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [14]
Udarbejdet af arbejdsgruppe fra Dansk Selskab for Infektionsmedicin og Dansk Fertilitetsselskab.
Version 9.
Udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin og Dansk Selskab for Gastroenterologi og Hepatologi.
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se.
:
Anne Øvrehus (tovholder), Peer Brehm Christensen, Nina Weis, Britta Tarp, Lone Mygind
National Strategi for Hepatitis C (Sundhedsstyrelsen 2023),
Kronisk viral hepatitis:
Nina Weis (tovholder), Peer Brehm Christensen, Alex Lund Laursen
Hepatitis B (2018),
Hepatitis C (2022),
HIV:
Antiretroviral terapi:
Jan Gerstoft (tovholder), Jens Lundgren, Henrik Nielsen, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen
Antiviral behandling af hiv smi.
Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom.
Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Antimicrobial Agents And Chemotherapy
5.02.2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Journal of the American Medical Association
4.02.2025
This noninferiority randomized clinical trial investigates whether administering tenofovir to pregnant individuals with hepatitis B virus beginning at gestational week 16 is noninferior to administering tenofovir beginning at gestational week 28 in preventing mother-to-child transmission.
BMC Infectious Diseases
2.02.2025
. Abstract. . Background. Hepatitis B-associated cirrhosis (HBC) is associated with severe complications and adverse clinical outcomes. This study aimed to develop and validate a predictive model for the occurrence of multiple complications (three or more) in patients with HBC and to explore the effects of multiple complications on HBC prognosis. . . . Methods.
BMC Infectious Diseases
1.02.2025
. Abstract. . Background. Hepatitis B virus (HBV) infection is associated with hepatitis, often progressing to liver cirrhosis or cancer, posing a significant public health challenge, particularly in Thailand. Previous research revealed that viral causes account for 18.5% of acute undifferentiated febrile illness (AUFI) in Asian countries.
BMC Infectious Diseases
1.02.2025
. Abstract. . Background. Human hepatitis is an inflammation of the liver brought on by the DNA virus known as the hepatitis B virus (HBV). Around the world, 240 million people are thought to have HBV in a chronic state. The prevalence of viral hepatitis is extremely high in Africa. Prior reports from various regions of the nation have indicated a variable prevalence of HBV infection. . .
BMC Infectious Diseases
1.02.2025
e in Uganda. Patients with HBV do not receive routine counselling and education, and there are limited resources for laboratory investigation coupled with a high loss to follow-up. This study set out to assess barriers and facilitators of integrated viral hepatitis B C and HIV care model to optimize screening uptake among mothers and newborns at health facilities in Koboko District, west Nile sub-region, Uganda. . . . Methods.
BMC Infectious Diseases
30.01.2025
e in Uganda. Patients with HBV do not receive routine counselling and education, and there are limited resources for laboratory investigation coupled with a high loss to follow-up. This study set out to assess barriers and facilitators of integrated viral hepatitis B C and HIV care model to optimize screening uptake among mothers and newborns at health facilities in Koboko District, west Nile sub-region, Uganda. . . . Methods.
Journal of the American Medical Association
29.01.2025
Hepatitis B virus (HBV) infection continues to pose a significant global health challenge despite the availability of effective vaccines for more than 4 decades and antivirals for almost 3 decades. The World Health Organization estimates that more than 254 million people worldwide are living with chronic HBV infection; 1.2 million new infections occurred in 2022.
Journal of Medical Virology
28.01.2025
Journal of Medical Virology, Volume 97, Issue 2, February 2025.
BMC Infectious Diseases
25.01.2025
. Abstract. . Background. Kyrgyzstan introduced universal hepatitis B childhood vaccination in 1999 to reduce the burden of hepatitis B. In 2016, aligned with the goal of controlling hepatitis B in the WHO European Region, a regional target of 0.5% was set for seroprevalence of hepatitis B surface antigen (HBsAg) among targeted birth cohorts.
BMC Infectious Diseases
23.01.2025
. Abstract. . Background. Kyrgyzstan introduced universal hepatitis B childhood vaccination in 1999 to reduce the burden of hepatitis B. In 2016, aligned with the goal of controlling hepatitis B in the WHO European Region, a regional target of 0.5% was set for seroprevalence of hepatitis B surface antigen (HBsAg) among targeted birth cohorts.
Emerg Microbes Infect
14.01.2025
Volume 14, Issue 1, December 2025 .
Journal of Infectious Diseases
10.01.2025
Abstract . Background . The incidence of metabolic-associated steatotic liver disease in patients with chronic hepatitis B is increasing annually; however, the interaction between hepatitis B virus (HBV) infection and lipid metabolism remains unclear. This study attempted to clarify whether fatty acid metabolism regulation could alleviate mitochondrial dysfunction caused by HBV infection.Methods .
American Journal of Tropical Medicine and Hygiene
9.01.2025
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 112 Issue: 1 Pages: 167-172. .
Journal of Infectious Diseases
7.01.2025
Abstract . Background . Restriction factors are host cell proteins that play a role in limiting virus replication. They form part of the intrinsic immune system and function as a first line of defense against viral infections. Hepatitis B virus (HBV) does not escape this rule and TREX1, a host restriction enzyme acts as an antiviral factor, leading to the inhibition of the virus.Methods . TREX1-expressing constructs were generated and modified by site-directed mutagenesis.
PLoS One Infectious Diseases
7.01.2025
by Patcharin Tepjanta, Thammakorn Saethang, Kazuhito Fujiyama, Ryo Misaki, Ingorn Kimkong . The 'a' determinant, a highly conformational region within the hepatitis B virus large surface protein (LHBs), is crucial for antibody neutralization and diagnostic assays. Mutations in this area can lead to conformational changes, resulting in vaccination failure, diagnostic evasion, and disease progression.
Journal of Medical Virology
4.01.2025
Journal of Medical Virology, Volume 97, Issue 1, January 2025.
BMC Infectious Diseases
4.01.2025
. Abstract. The natural stages of chronic hepatitis B can be divided into four stages according to changes in virology, biochemistry, and pathology. However, there have been significant differences in the recommended stage criteria in the several major guidelines for chronic hepatitis B, especially regarding the immune tolerance phase.
PLoS One Infectious Diseases
1.01.2025
by Sayamon Hongjaisee, Woottichai Khamduang, Nang Kham-Kjing, Nicole Ngo-Giang-Huong, Arunrat Tangmunkongvorakul . During the COVID-19 pandemic, sex workers (SW) were one of the vulnerable groups affected by lockdown measures. COVID-19 had also disrupted HIV/Sexually transmitted infection (STI) testing and treatment services for sex workers due to numerous restrictions in specialist medical care.
BMC Infectious Diseases
29.12.2024
. Abstract. . Background. Hepatitis B virus (HBV) infection remains a major health challenge in Nigeria, with high prevalence rates among pregnant women. The prevalence of overt and occult hepatitis B infection (HBIOV and HBIOC) among pregnant women was investigated to understand the burden and associated risk factors in this population. . . . Methods.
Aktuelle smitsomme sygdomme [14]
Aktuelle smitsomme sygdomme [14]
Morbidity and Mortality Weekly Report (MMWR)
5.12.2024
This report describes an update to the recommendation for Hepatitis B vaccination in adults aged 19-59 years.
Medscape Infectious Diseases
31.08.2024
The rules about whom to screen and vaccinate for hepatitis B are now more clinician-friendly. . The Curbsiders
Morbidity and Mortality Weekly Report (MMWR)
2.08.2024
This report describes progress toward eliminating hepatitis B and C in the country of Georgia.
Morbidity and Mortality Weekly Report (MMWR)
25.07.2024
This report describes vaccination efforts to eliminate mother-to-child hepatitis B.
Medscape Infectious Diseases
15.05.2024
The U.S. drug regulator has declined to approve expanded use of Dynavax Technologies' hepatitis B vaccine in a section of patients, citing insufficient data over destruction. . Reuters Health Information
Medscape Infectious Diseases
22.01.2025
The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven different scenarios: Pregnancy, breastfeeding, pediatrics, malignancy, tuberculosis infection, hepatitis B or C infection, and HIV disease. . Medscape Medical News
ProMED
12.01.2025
.2024.107291 . . Natural immunity and protection against variants in South African. children through five COVID-19 waves: A prospective study . Zar et al. Int J Infect Dis. 2025;150:107300 .
doi.org/10.1016/j.ijid.2024.107300 . . Total burden of hepatitis B and C attributed to injecting drug use in. 204 countries and territories from 1990 to 2021: Analyses based on the. Global Burden of Disease Study 2021 . Huang et al. Int J Infect Dis. 2025;150:107293 .
Statens Serum Institut
3.12.2024
De nyeste tal fra Statens Serum Institut viser, at der ikke blev fundet nogen hiv-positive bloddonorer i bloddonorscreeningen i 2019 og kun ganske få tilfælde af hepatitis B og C.
Eurosurveillance latest updates
8.11.2024
. Background. Recent hepatitis A virus outbreaks in Europe affecting men who have sex with men (MSM) and ongoing hepatitis B virus transmission among MSM underscore the ongoing need for viral hepatitis prevention in this population. . . Aim. To describe viral hepatitis knowledge and associated factors among MSM in the WHO European Region to inform targeted prevention. . . Methods.
Eurosurveillance latest updates
8.11.2024
ars (IQR: 27–47). Vaccination for hepatitis A and B was recommended and free for MSM in 7 and 18 of 43 countries, respectively. Of all respondents, 48% (n = 50,966) reported ever being vaccinated against hepatitis A, and 53% (n = 56,889) against hepatitis B.
Eurosurveillance latest updates
26.10.2024
disease (aOR: 4.29), HIV infection (aOR: 3.00) and hepatitis B/C (aOR: 2.11). . . Conclusions. Hepatitis E hospitalisations have increased in Spain in recent years, being more severe in cases with older age, chronic hepatic diseases and HIV infection. A greater incidence in men over 40 years and a possible seasonality were observed. Further studies are needed to assess the seasonality, geographical distribution and impact of the disease to guide public health actions for prevention and control. . . .
Eurosurveillance latest updates
17.08.2024
above 1 per 100,000 population, we included 16 infectious diseases. We calculated median male proportion and interquartile range by disease, year, country and age group and used boxplots to identify outliers. . . Results . For campylobacteriosis, acute hepatitis B, Legionnaires’ disease, malaria and HIV and AIDS, all countries had male proportion above 50%.
Medscape Infectious Diseases
29.07.2024
This requires sensitivity to stigmas and awareness of hepatitis B and C prevalence in local communities. . Medscape Medical News